Global Cosmetic Surgery and Service Market Report 2015-2019

MUMBAI, March 11, 2015 /PRNewswire/ --

Global Cosmetic Surgery & Services Market Analysis 2015-2019 is the latest analysis on this vertically growing market. It is currently worth over $20 billion and is set to rise to over $27 billion by 2019.

This comprehensive report is supported by 60 tables & figures over 275 pages and is presented as follows:

The global market for cosmetic surgery services by the following sub-categories are presented: 

• By Segment (Body Contouring, Facial Reconstruction/Rejuvenation, Cosmetic Implants)
• By Geography (North America, Europe, Asia/Pacific, Latin America)
• By Product Segment (Facial injectables, Botox, Dermafillers, Neuromodulators)
• By Energy Based and Other Devices (Home-use Aesthetic Devices)
• By Company (e.g Allergen, Mentor, Galderma, Valeant, Merz, Syneron, Zetiq, Ulthera, Cynosure, Solta/Valeant, Alma/Fosun Pharma)

Business strategy information can be gleaned from the following high impact analyses: 

• Geographic Share of Cosmetic Surgery Procedures
• Minimally-Invasive Cosmetic Procedures
• Most Popular Minimally-Invasive Procedures Globally
• Top Five Countries for Noninvasive Cosmetic Procedures
• Top Five Noninvasive Cosmetic Procedures in the U.S.
• Emergence of Plastic Surgery Tourism (USA, Mexico, Brazil, Costa Rica, UK, Poland, Hungary, Thailand, Malaysia, India)

A comprehensive account of company product portfolios are provided for 116 Cosmetic Surgery and Service providers globally including: 

• Allergen
• Mentor
• Galderma
• Valeant
• Merz
• Syneron
• Zetiq
• Ulthera
• Cynosure
• Solta/Valeant
• Alma/Fosun Pharma

To order this report and request for sample page: 

https://www.bharatbook.com/healthcare-market-research-reports-643332/global-cosmetic-surgery-service.html

You will discover a wealth of strategic information throughout this report and find out - 

• Who is leading the market?
• Which companies are struggling?
• What has the most attractive acquisition potential?

It is specifically written for the busy high level professional in mind - Presidents, VP's, C-suite managers, MD, commercial director, global compensation manager and leaders of marketing, strategic planning and business development.

To date, the US is the largest market for cosmetic procedures globally. The cosmetic surgery service segment earned revenues of circax million in 2013 with a CAGR of x% and reach $x million by 2019. Within this the facial reconstruction sector generated $x million in 2013 with a CAGR of x%; it is predicted to reach $x million by 2019.

A recently published report by The American Society of Plastic Surgeons indicated that service revenues for plastic surgeries rise and fall with economic trends. The journal has analyzed the trends in revenues and their possible relationships with different economic indicators. According to their analysis, revenues from surgical procedures are reflected by indicators of macroeconomic climate such as stock market averages. When the stock exchange average rises, the revenues from cosmetic surgeries also rise. When the unemployment rate goes up, the revenues from cosmetic surgeries go down. In the U.S. which is the largest market for cosmetic procedures, the overall revenues increased 20%, but there was 10% decline in service revenues from surgical procedures such as breast augmentation and facelift.

On the other hand, trends in minimally invasive procedures are seen reflecting microeconomic indicators. Revenues from minimally invasive procedures increase along with home prices, disposable income per capita and real Gross Domestic Product per capita. Thus, in the recent past, there was circa 200% increase in service revenues generated by minimally invasive cosmetic procedures such as botulinum toxin and dermal fillers. The market share for service revenues from these procedures increased from 30% in 2000 to about 50% in past two years. Consequently, the service revenues from surgical procedures have nearly remained stable. The ASPS sugeons earned service revenues of $1,040 million, $1,014 million and $1,064 million for breast augmentation surgeries in 2011, 2012 and 2013 respectively.

Nonsurgical treatments lead the way across the globe and they are broadly classified into three major categories: injectable products, energy based devices and active cosmetics. The injectable products include neurotoxins such as Botox and dermal fillers such as Restylane and they have the largest market share. These are followed by energy-based devices such as lasers, radio frequency and intense pulsed light (IPL). The cosmeceuticals include skin care, eye care, skin lightening and scar care products.

The North American market accounts for about 45% of the global market. However, the dominance of the U.S. is shifting towards Asia, particularly in the energy- based devices segment. Asia is regarded as the next frontier and the number of physicians and clinics in China and India has been steadily rising, along with medical tourism in the region. In the injectables and devices category, the E.U. occupies the second position behind the U.S. Brazil continues to be a strong market for aesthetics and cosmetic procedures. Russian market is also experiencing fast growth than many E.U. countries and the Russian market is particularly strong for devices and topicals.

Along with the global giants such as Allergan, Galderma and Merz, a lot of smaller players are offering wrinkle relaxing agents and wrinkle fillers. These products have only temporary effects requiring repeated procedures. The market for these products is nearing maturity and they are widely accepted only in the U.S. and E.U., whereas, permanent fillers are widely in demand in Asia. Artefill is considered to be a semi-permanent to permanent filler. It contains a synthetic ingredient known as polymethyl methacrylate (PMMA) mixed with animal collagen. Use of off-the-shelf dermal fillers and fillers containing lidocaine for pain management is becoming a gold standard in the E.U. and U.S. markets.

Aesthetic practitioners have now the choice of new instrumentations such as soft and bendable needles, blunt-tip cannulas and injector pens for minimally invasive procedures. Recent years have seen wide acceptance by consumers for microneedle treatments administered via handheld guns, for restoring skin with vitamins, amino acids and hyaluronic acid. Consumer aesthetic products such as "micro- botox" and "bro-tox" are experiencing a steady growth. Adipose derived stem cells (ADSC) have gained acceptance for rejuvenating face and breasts, and stem cells from green apple, lilac and alpine roses are now being used as ingredients in topical cosmetics. Facial treatments have gained a significant market share with the availability of plenty of off label products. New technologies to treat excessive sweating, cryoneuromodultion for wrinkles and eradication of toenail fungus offer new areas for physicians.

Another growth market is for body shaping procedures that involves reduction of fat, cellulite, skin laxity and vein removal. An injectable drug, currently in clinical trials is most likely to become a game changer in body contouring segment in the near future. On July 10, 2014, FDA has accepted the filing of New Drug Application (NDA) for the drug ATX-101 (deoxycholic acid) by Kythera Biopharmaceuticals. Plug-in at-home devices for treating sun damage, hair removal, skin decoloration, acne, hair growth, skin texture, microdermabrasion and cellulite continue to expand particularly in developed markets. As a new innovation, the aesthetic market is expected to witness the launching of transepidermal drug delivery technologies for facilitating topical treatments.

Benefits of Investing in our Cutting-Edge Reports: 

• Clients receive complementary content* with mid-level and enterprise wide licenses
• Post-sale complementary consultation with senior expert analyst is included
• Use of tables and figures in your own reports and presentations is permitted
• Each report provides straight-talking strategic analysis & sector intelligence
• All reports are updated each quarter to give you the most up-to-date information

Table of Content 

• Executive Summary
• Summary: Cosmetic Surgery Market
• Reconstructive Plastic Surgery: An Overview
• Cosmetic Surgical Procedures: An Overview
• Minimally-Invasive Cosmetic Procedures: An Overview
• Physician-Dispensed Cosmeceuticals: An Overview
• Cosmetic Surgery Technologies: An Overview
• Emergence of Plastic Surgery Tourism: An Overview
• Market Analysis
• Company Profiles
• Cosmetic Surgery: Industry Participants and their Participating Market Segments

Companies Covered 

• Aerolase Corp.
• Adoderm GmbH
• Aesthetic Dermal S.L.
• Allergan Inc.
• Allied Biomedical
• Alma Lasers Ltd.
• Amiea Med
• Andrew Technologies LLC
• Anika Therapeutics Inc.
• Anteis S.A.
• Apira Science Inc.
• Aqtis Medical B.V.
• Baby Quasar
• Benev Company
• Biopelle Inc.
• Biotechnique Avance
• Breit Aesthetics Ltd.
• BTL Industries Inc.
• Canfield Imaging Systems
• Carol Cole Co.
• Chromogenex PLC
• Classys Inc.
• Contura International A/S
• CoolTouch Inc.
• Cutera Inc.
• Cynosure Inc.
• Deka Laser Technologies Inc.
• DermaMed Solutions LLC
• Eclipse Aesthetic LLC
• Edge Systems LLC
• Ellipse A/S
• Ellman International Inc.
• Endymed Medical Ltd.
• Energist Ltd.
• Envy Medical Inc.
• E-One-IPL
• Episciences Inc.
• Erchonia Corp.
• EunSung Global Corp.
• Eurosilicone S.A.S.
• Focus Medical
• Fotona D.D.
• Galderma S.A.
• General Project S.R.L.
• Hironic Co. Ltd.
• H&O Equipment N.V/S.A
• Home Skinovations Ltd.
• Hongkong Spring International Industry Ltd.
• Human Med A.G.
• Ilooda Co. Ltd.
• Iluminage Beauty
• Invasix Ltd.
• Ispen Biopharmacuticals Inc.
• Jeisys Medical Inc.
• JeNu Biosciences Inc.
• Laboratoires FILORGA
• Lasering S.R.L.
• Lexington International LLC
• L'Oreal International
• LSO Medical Groupe
• Lumenis Ltd
• Lumiere Medical
• Lutronic Corp.
• Medixsysteme
• Mentor Worldwide LLC
• Merz Aesthetics Inc.
• Mesoestetic Pharma Group
• Myoscience Inc.
• Nagor Ltd.
• Novoxel Ltd.
• Obagi Medical Products Inc.
• Pantec Biosolutions AG
• Pacific Bioscience Laboratories Inc.
• PCA Skin
• Philips
• Photocadmus Technologies Spain Ltd.
• Photomedex Inc.
• PhytoCeuticals Inc.
• Pierre Fabre Dermo-Cosmetique USA Inc.
• Polytech Health & Aesthetics GmbH
• Pollogen Ltd
• Prollenium Medical Technologies Inc.
• Quanta Systems S.P.A.
• Radiancy Inc.
• Restoration Robotics Inc.
• Rhonda Allison Clinical Enterprises
• Sciton
• SharpLight Technologies Ltd.
• Sientra Inc.
• Sinclair Is Pharma
• SkinCeuticals Inc.
• Skin Tech
• Solta Medical Inc.
• Spectrum Brands/Remington
• Spencer Forrest Inc.
• Suneva Medical Inc.
• Super Grow Lasers Inc.
• Surgiform Technology Ltd.
• SurgiSil LLC
• Sybaritic Inc.
• Syneron Medical Ltd.
• Tavger Ltd.
• TavTech Ltd.
• Teoxane Laboratories
• The Dezac Group Ltd.
• Theradome Inc.
• ThermiAesthetics
• Tria Beauty Inc.
• Ulthera Inc.
• Venus Concepts Ltd.
• Viora
• Won Tech Co. Ltd.
• Ya-Man Ltd.
• Zeltiq Aesthetics Inc.

Related Reports 

• Global Neurosurgery Market 2015-2019
• Cosmetic Surgery 2014 - Market Report
• Global Database of the Top 1000 Cosmetic and Beauty Product Stores - Company Names, Financial Performance, and Contact Details

About Bharat Book Bureau 

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact Details:
Poonam
Bharat Book Bureau
India: +91-22-27810772, 27810773
Blog: https://www.bharatbook.com/blog/
W: https://www.bharatbook.com/
E: [email protected]